Cargando…
Identification of fibrinogen as a natural inhibitor of MMP-2
Non-genetic MMP-2 insufficiency is a relatively unexplored condition which could be induced by pathological overexpression of endogenous MMP-2 inhibitors such as TIMPs and/or the acute phase reactant alpha-2-macroglobulin. Here, we investigate the hypothesis that human fibrinogen (FBG) – an acute ph...
Autores principales: | Sarker, Hassan, Hardy, Eugenio, Haimour, Ayman, Maksymowych, Walter P., Botto, Lorenzo D., Fernandez-Patron, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416301/ https://www.ncbi.nlm.nih.gov/pubmed/30867536 http://dx.doi.org/10.1038/s41598-019-40983-y |
Ejemplares similares
-
Comparative Serum Analyses Identify Cytokines and Hormones Commonly Dysregulated as Well as Implicated in Promoting Osteolysis in MMP-2-Deficient Mice and Children
por: Sarker, Hassan, et al.
Publicado: (2020) -
The Emerging Role of Epigenetic Mechanisms in the Causation of Aberrant MMP Activity during Human Pathologies and the Use of Medicinal Drugs
por: Sarker, Hassan, et al.
Publicado: (2021) -
Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis
por: Hardy, Eugenio, et al.
Publicado: (2021) -
Could a Non-Cellular Molecular Interactome in the Blood Circulation Influence Pathogens’ Infectivity?
por: Hardy, Eugenio, et al.
Publicado: (2023) -
Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis
por: Hussain, Faraz S., et al.
Publicado: (2023)